Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Thrombotic Thrombocytopenic Purpura (TTP) is a rare blood disorder characterized by clotting in small blood vessels of the body (thromboses), resulting in a low platelet count. Symptoms include bleeding into the skin or mucus membranes, confusion, fever, headache, heart rate, shortness of breath, speech changes, weakness, and yellowish color to the skin (jaundice).
The TTP pipeline drugs market research report outlays comprehensive information on the TTP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type, that are being developed by companies/universities. It also reviews key players involved in TTP targeted therapeutics development with respective active and dormant or discontinued projects.
TTP Pipeline Drugs Market Segmentation by Targets
Some of the primary targets in the Thrombotic Thrombocytopenic Purpura pipeline drugs market are A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13, Von Willebrand Factor, and Plasminogen.
TTP Pipeline Drugs Market Analysis, by Targets
To know more about the targets in the TTP pipeline drugs market, download a free report sample
TTP Pipeline Drugs Market Segmentation by Mechanisms of Action
The primary mechanisms of action in the Thrombotic Thrombocytopenic Purpura pipeline drugs market are Von Willebrand Factor Inhibitor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Activator, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Replacement, and Plasminogen Activator.
TTP Pipeline Drugs Market Analysis, by Mechanisms of Action
To know more about the MoA in the TTP pipeline drugs market, download a free report sample
TTP Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Thrombotic Thrombocytopenic Purpura pipeline drugs market are Intravenous and Subcutaneous.
TTP Pipeline Drugs Market Analysis, by Routes of Administration
To know more about the RoA in the TTP pipeline drugs market, download a free report sample
TTP Pipeline Drugs Market Segmentation by Molecule Type
The key molecule types in the TTP pipeline drugs market are Recombinant Enzyme, Aptamer, Fusion Protein, Gene Therapy, Gene-Modified Cell Therapy, Monoclonal Antibody, and Recombinant Protein.
TTP Pipeline Drugs Market Analysis, by Molecule Type
To know more about the molecule type in the TTP pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the TTP pipeline drugs market are GC Biopharma Corp, KM Biologics Co Ltd, PlateletBio, Sanofi, TagCyx Biotechnologies, Takeda Pharmaceutical Co Ltd, and TargED Biopharmaceuticals BV.
TTP Pipeline Drugs Market Analysis, by Leading Companies
To know more about the leading companies in the TTP pipeline drugs market, download a free report sample
TTP Pipeline Drugs Market Report Overview
Key Targets | A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13, Von Willebrand Factor, and Plasminogen |
Key Mechanisms of Action | Von Willebrand Factor Inhibitor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Activator, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Replacement, and Plasminogen Activator |
Key Routes of Administration | Intravenous and Subcutaneous |
Key Molecule Types | Recombinant Enzyme, Aptamer, Fusion Protein, Gene Therapy, Gene-Modified Cell Therapy, Monoclonal Antibody, and Recombinant Protein |
Key Companies | GC Biopharma Corp, KM Biologics Co Ltd, PlateletBio, Sanofi, TagCyx Biotechnologies, Takeda Pharmaceutical Co Ltd, and TargED Biopharmaceuticals BV |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
KM Biologics Co Ltd
PlateletBio
Sanofi
TagCyx Biotechnologies
Takeda Pharmaceutical Co Ltd
TargED Biopharmaceuticals BV
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets in the TTP pipeline drugs market?
Some of the targets in the TTP pipeline drugs market are A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13, Von Willebrand Factor, and Plasminogen.
-
What are the mechanisms of action in the TTP pipeline drugs market?
The primary mechanism of action in the TTP pipeline drugs market are Von Willebrand Factor Inhibitor, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Activator, A Disintegrin And Metalloproteinase With Thrombospondin Motifs 13 Replacement, and Plasminogen Activator.
-
What are the routes of administration in the TTP pipeline drugs market?
The routes of administration in the TTP pipeline drugs market are Intravenous and Subcutaneous.
-
What are the molecule types in the TTP pipeline drugs market?
The molecule types in the TTP pipeline drugs market are Recombinant Enzyme, Aptamer, Fusion Protein, Gene Therapy, Gene-Modified Cell Therapy, Monoclonal Antibody, and Recombinant Protein.
-
Which are the leading companies in the TTP pipeline drugs market?
Some of the leading companies in the TTP pipeline drugs market are GC Biopharma Corp, KM Biologics Co Ltd, PlateletBio, Sanofi, TagCyx Biotechnologies, Takeda Pharmaceutical Co Ltd, and TargED Biopharmaceuticals BV.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.